Zacks Investment Research
Thu, Jul 2nd, 2026
Most Recent Stories
As July begins, investors can enhance returns by taking a more active approach to stock selection, identifying potential breakout opportunities within well-defined price ranges. Under this strategy, a...
The UK government has unveiled a substantial £15 billion (approximately $20 billion) boost to its defense budget over the next four years as part of the newly published Defence Investment Plan (DIP)....
For investors seeking momentum, Alpha Blue Capital US Small-Mid Cap Dynamic ETF ABCS is probably on the radar now. The fund just hit a 52-week high and jumped 19.9% from its 52-week low price of $28.19...
Powell Industries, Inc. POWL is benefiting from its strong foothold and healthy project activities across the electric utility and commercial & other industrial markets. In the second quarter of fiscal...
The U.S. stock market wrapped up the first half of 2026 on a strong note.The Dow Jones advanced 8.9% during the first six months of the year, marking its best first-half performance since 2021, when it...
Shares of Universal Insurance Holdings, Inc. UVE have rallied 66.3% in the past year, outperforming the industry’s growth of 3.7%. Its share price closed at $42.24 on Wednesday and reached a 52-week...
Regional banks continue to operate in an environment influenced by interest rate movements, regulatory oversight and evolving customer expectations. Within this backdrop, Ohio Valley Banc Corp. OVBC and...
Innodata's INOD first-quarter 2026 results suggest that its improving profitability reflects more than just strong demand for AI services. The company delivered an adjusted gross margin of 47%, well above...
On the Fourth of July, America celebrates 250 years of freedom. The beloved American holiday, known for barbecues, fireworks, and patriotic celebrations, draws special attention this year as inflationary...
AtaiBeckley ATAI has drawn more investor attention in 2026 as its clinical calendar has sharpened. The stock’s rally reflects growing confidence in its psychiatric drug pipeline, but the investment...
